Literature DB >> 22753934

A protective role for human IL-10-expressing CD4+ T cells in colitis.

Dilini C Ranatunga1, Amritha Ramakrishnan, Priyanka Uprety, Fengying Wang, Hao Zhang, Joseph B Margolick, Cory Brayton, Jay H Bream.   

Abstract

IL-10 is an immunoregulatory cytokine expressed by numerous cell types. Studies in mice confirm that different IL-10-expressing cell subsets contribute differentially to disease phenotypes. However, little is known about the relationship between cell- or tissue-specific IL-10 expression and disease susceptibility in humans. In this study, we used the previously described human (h)IL10BAC transgenic model to examine the role of hIL-10 in maintaining intestinal homeostasis. Genomically controlled hIL-10 expression rescued Il10(-/-) mice from Helicobacter-induced colitis and was associated with control of proinflammatory cytokine expression and Th17 cell accumulation in gut tissues. Resistance to colitis was associated with an accumulation of hIL-10-expressing CD4(+)Foxp3(+) regulatory T cells specifically within the lamina propria but not other secondary lymphoid tissues. Cotransfer of CD4(+)CD45RB(lo) cells from Il10(-/-)/hIL10BAC mice rescued Rag1(-/-) mice from colitis, further suggesting that CD4(+) T cells represent a protective source of hIL-10 in the colon. In concordance with an enhanced capacity to express IL-10, CD4(+)CD44(+) T cells isolated from the lamina propria exhibited lower levels of the repressive histone mark H3K27Me3 and higher levels of the permissive histone mark acetylated histone H3 in both the human and mouse IL10 locus compared with the spleen. These results provide experimental evidence verifying the importance of T cell-derived hIL-10 expression in controlling inflammation within the colonic mucosa. We also provide molecular evidence suggesting the tissue microenvironment influences IL-10 expression patterns and chromatin structure in the human (and mouse) IL10 locus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22753934      PMCID: PMC3401244          DOI: 10.4049/jimmunol.1103421

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.

Authors:  D J Berg; N Davidson; R Kühn; W Müller; S Menon; G Holland; L Thompson-Snipes; M W Leach; D Rennick
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

2.  Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis.

Authors:  Holm H Uhlig; Janine Coombes; Christian Mottet; Ana Izcue; Claire Thompson; Andrea Fanger; Andrea Tannapfel; Jason D Fontenot; Fred Ramsdell; Fiona Powrie
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

3.  Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis.

Authors:  E Crawley; R Kay; J Sillibourne; P Patel; I Hutchinson; P Woo
Journal:  Arthritis Rheum       Date:  1999-06

4.  Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus.

Authors:  R J Cahill; C J Foltz; J G Fox; C A Dangler; F Powrie; D B Schauer
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  Refined histopathologic scoring system improves power to detect colitis QTL in mice.

Authors:  Andre Bleich; Michael Mähler; Claudia Most; Edward H Leiter; Elisabeth Liebler-Tenorio; Charles O Elson; Hans J Hedrich; Brigitte Schlegelberger; John P Sundberg
Journal:  Mamm Genome       Date:  2004-11       Impact factor: 2.957

6.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.

Authors:  F Powrie; M W Leach; S Mauze; S Menon; L B Caddle; R L Coffman
Journal:  Immunity       Date:  1994-10       Impact factor: 31.745

Review 7.  CD4+ memory T cells: functional differentiation and homeostasis.

Authors:  Brigitta Stockinger; Christine Bourgeois; George Kassiotis
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

8.  T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation.

Authors:  Axel Roers; Lisa Siewe; Elke Strittmatter; Martina Deckert; Dirk Schlüter; Werner Stenzel; Achim D Gruber; Thomas Krieg; Klaus Rajewsky; Werner Müller
Journal:  J Exp Med       Date:  2004-11-08       Impact factor: 14.307

9.  An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation.

Authors:  C Asseman; S Mauze; M W Leach; R L Coffman; F Powrie
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

10.  IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis.

Authors:  Marika C Kullberg; Dragana Jankovic; Carl G Feng; Sophie Hue; Peter L Gorelick; Brent S McKenzie; Daniel J Cua; Fiona Powrie; Allen W Cheever; Kevin J Maloy; Alan Sher
Journal:  J Exp Med       Date:  2006-10-09       Impact factor: 14.307

View more
  9 in total

1.  Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+ CD45RB high T Cells into Immunodeficient Mice.

Authors:  Erin C Steinbach; Gregory R Gipson; Shehzad Z Sheikh
Journal:  J Vis Exp       Date:  2015-04-21       Impact factor: 1.355

2.  Cell-Specific Requirements for STAT Proteins and Type I IFN Receptor Signaling Discretely Regulate IL-24 and IL-10 Expression in NK Cells and Macrophages.

Authors:  Djeneba Dabitao; Christian M Hedrich; Fengying Wang; Vimvara Vacharathit; Jay H Bream
Journal:  J Immunol       Date:  2018-02-07       Impact factor: 5.422

3.  Pathogenic properties of enterohepatic Helicobacter spp. isolated from rhesus macaques with intestinal adenocarcinoma.

Authors:  Kvin Lertpiriyapong; Laurence Handt; Yan Feng; Thomas W Mitchell; Kenneth E Lodge; Zeli Shen; Floyd E Dewhirst; Sureshkumar Muthupalani; James G Fox
Journal:  J Med Microbiol       Date:  2014-04-02       Impact factor: 2.472

4.  Protein Phosphatase 1α and Cofilin Regulate Nuclear Translocation of NF-κB and Promote Expression of the Anti-Inflammatory Cytokine Interleukin-10 by T Cells.

Authors:  Guido H Wabnitz; Henning Kirchgessner; Beate Jahraus; Ludmila Umansky; Shirish Shenolikar; Yvonne Samstag
Journal:  Mol Cell Biol       Date:  2018-10-29       Impact factor: 4.272

5.  Macrophage-derived IL-10 mediates mucosal repair by epithelial WISP-1 signaling.

Authors:  Miguel Quiros; Hikaru Nishio; Philipp A Neumann; Dorothee Siuda; Jennifer C Brazil; Veronica Azcutia; Roland Hilgarth; Monique N O'Leary; Vicky Garcia-Hernandez; Giovanna Leoni; Mingli Feng; Gabriela Bernal; Holly Williams; Priya H Dedhia; Christian Gerner-Smidt; Jason Spence; Charles A Parkos; Timothy L Denning; Asma Nusrat
Journal:  J Clin Invest       Date:  2017-08-07       Impact factor: 19.456

6.  CD103+ CD11b+ Dendritic Cells Induce Th17 T Cells in Muc2-Deficient Mice with Extensively Spread Colitis.

Authors:  Ulf A Wenzel; Caroline Jonstrand; Gunnar C Hansson; Mary Jo Wick
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

7.  Endometrial regenerative cells as a novel cell therapy attenuate experimental colitis in mice.

Authors:  Yongcheng Lv; Xiaoxi Xu; Bai Zhang; Guangying Zhou; Hongyue Li; Caigan Du; Hongqiu Han; Hao Wang
Journal:  J Transl Med       Date:  2014-12-05       Impact factor: 5.531

8.  The development of colitis in Il10-/- mice is dependent on IL-22.

Authors:  Dilini C Gunasekera; Jinxia Ma; Vimvara Vacharathit; Palak Shah; Amritha Ramakrishnan; Priyanka Uprety; Zeli Shen; Alexander Sheh; Cory F Brayton; Mark T Whary; James G Fox; Jay H Bream
Journal:  Mucosal Immunol       Date:  2020-01-13       Impact factor: 7.313

9.  Plasmacytoid dendritic cells are crucial in Bifidobacterium adolescentis-mediated inhibition of Yersinia enterocolitica infection.

Authors:  Alexandra Wittmann; Ingo B Autenrieth; Julia-Stefanie Frick
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.